Researchers will investigate if chronic pain associated with osteoarthritis has a neuropathic pain component that can be modulated by pleasant and unpleasant sensory stimuli.
Researchers will evaluate if the drug rapamycin can reverse the negative heart changes associated with subvalvular aortic stenosis, the most common congenital heart defect in dogs.
Researchers will develop a new core vaccine that is safe and can provide superior protection against three common cat viruses, feline herpesvirus-1 (FHV-1), feline calicivirus (FCV) and feline panleukopenia virus (FPV).
Researchers will evaluate the effect of blocking a key protein involved in fat metabolism that may help improve quality of life for cats with osteoarthritis.